Navigation Links
Strand Diagnostics and Manhattan Labs Partner to Create myPAP test
Date:6/17/2013

INDIANAPOLIS and NEW YORK, June 17, 2013 /PRNewswire/ -- Strand Diagnostics, LLC, maker of the know error® system for breast and prostate biopsies and Manhattan Labs, a premier clinical laboratory serving Manhattan and the tri-state area, today announced the availability of the myPAP™ test. Developed to complement a Papanicolaou (Pap) test by confirming a patient's identity and helping physicians to proceed confidently with treatment recommendations, the myPAP test compares the DNA profiles of the Pap specimen with a reference DNA sample taken via cheek swab at the time of the Pap test. This state-of-the-art testing is available exclusively for Manhattan Labs' customers who perform Pap testing.

(Photo: http://photos.prnewswire.com/prnh/20130617/NE32486 )

Cervical cancer is the sixth leading cause of cancer-related death, claiming the lives of 275,000 women across the globe annually. Approximately 55 million Pap tests are performed annually in the U.S. to detect the presence of dysplasia or cancerous cells on the surface of the cervix. Pap tests are commonly performed in a healthcare provider's office on women ages 21-65, depending on their individual risk factors.

"If it's caught early, cervical cancer is treatable and curable," said Lawrence J. Levitan M.D., a New York City OB/Gyn. "However, cancer treatment can be life-altering, so it is imperative that we ensure we are providing treatment to the right patient at the right time. The myPAP test will allow us to easily provide this confirmation before any surgical intervention and treatment takes place." 

Pap testing can include up to a 20-step process from the time when the specimen is collected to when laboratory results are completed.  Anywhere along this pathology testing cycle, a specimen identification error can occur. The innovative myPAP test utilizes patient-specific bar coding and forensic chain-of-custody principles for the purpose of reducing errors, and advanced DNA testing (also known as DNA Specimen Provenance Assignment or "DSPA" testing) to match test results with the right patient so as to avoid adverse patient outcomes.

"At Manhattan Labs, we have a long history with clinical testing, and we understand first-hand the complexity of the diagnostic testing process. The potential for identification errors can delay much-needed treatment or even worse, cause the wrong patients to receive the wrong treatments. In the case of Pap testing, where screening guidelines are changing, reducing diagnostic errors is imperative," said Ken Cerney, CEO of Manhattan Labs. "Providing clinicians with the myPAP test allows physicians and their patients the peace of mind to confidently proceed with treatment when required. The myPAP test just makes sense!" 

"At Strand, we have applied our historical competency as a forensics lab to help more than 100,000 individuals with a positive test result confirm that this result really is their result. Using the know error system has helped protect patients from undetected misidentification issues which studies have shown occur in as many as 3.5 percent of the cases," said Ted Schenberg, CEO of Strand Diagnostics. "We commend Manhattan Labs for having the foresight to understand the benefits of introducing DSPA testing to a new group of individuals undergoing Pap testing, utilizing the myPAP test."

To learn more about the myPAP test, please visit: http://manhattanlabs.com/myPAP.

About Strand Diagnostics
As a comprehensive provider of identity confirmation testing services, Strand Diagnostics has a strong track record of using cutting edge technology to solve complex problems in the criminal justice system and life sciences sector. The company's forensic division supports law enforcement agencies with forensic DNA testing services. Strand Diagnostics's healthcare division developed and markets the know error® system, which is used by physicians and laboratories to complete the diagnostic testing cycle for cancer and other histopathological conditions by ensuring patients are always matched with the appropriate diagnosis. With a premier team of scientists and state-of-the-art facility, Strand Diagnostics is at the forefront of molecular testing in a variety of market settings. Visit Strand Diagnostics online at www.StrandDiagnostics.com.  

About Manhattan Labs
Manhattan Physicians Laboratories, LLC ("Manhattan Labs") was founded in 2008 with the goal of creating the premier service-oriented, high-quality independent clinical laboratory in New York City and the surrounding tri-state area. Combining the latest in clinical laboratory technology, personalized service, exceptional turnaround time and easy-to-access results, Manhattan Labs is continuing to elevate the standards and set a new benchmark of service in the laboratory industry. www.ManhattanLabs.com

Contact:

For Know Error inquiries:
Kirsten Fallon
Schwartz MSL Boston
781-684-0770
knowerror@SchwartzMSL.com

For Manhattan Labs inquiries:
Laura Johnson
Manhattan Labs
212-874-0050
ljohnson@manhattanlabs.com 


'/>"/>
SOURCE Strand Diagnostics, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Isis Pharmaceuticals Demonstrates The Potential Of Single-Stranded RNA-Like Antisense Technology To Activate The RNAi Pathway
2. Trovagene and Strand Life Sciences Agree to Validate and Commercialize Urine-Based HPV Test in India and South Asia
3. Strand Diagnostics appoints new President
4. QBC Diagnostics Awarded GSA Contract
5. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
6. Heightened Awareness, Coupled with Expanding Patient Pool, Stimulates Sleep Apnea Diagnostics and Sleep Services Market, Says Frost & Sullivan
7. Ariosa Diagnostics to Present and Exhibit at the 16th International Conference on Prenatal Diagnosis and Therapy
8. ZINO Society Targets Medical Devices, Healthcare IT and Diagnostics
9. Quest Diagnostics To Speak At The Wells Fargo Securities 2012 Healthcare Conference
10. Breakthrough Prostate Cancer Diagnostics
11. NicOx Signs Worldwide Licensing Agreement With Rapid Pathogen Screening, Inc. For Ophthalmic Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Global MEMS Devices Medical Market Analysis 2016 - Forecast to ... The report contains up to date financial ... reliable analysis. Assessment of major trends with potential impact on ... dive analysis of market segmentation which comprises of sub markets, ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
(Date:6/23/2016)... , , , WHEN: ... , , , , LOCATION: , , , Online, with ... , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice ... Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... industry is witnessing an exceptional era. Several new demand spaces, such ...
Breaking Medicine Technology:
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users ... - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 ... Pro X . Simply select a ProHand generator and drag it above media or ...
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/25/2016)... ... 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland ... iHire in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness ... & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
Breaking Medicine News(10 mins):